236 related articles for article (PubMed ID: 29775410)
1. Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition.
Parikh VN; Liu J; Shang C; Woods C; Chang AC; Zhao M; Charo DN; Grunwald Z; Huang Y; Seo K; Tsao PS; Bernstein D; Ruiz-Lozano P; Quertermous T; Ashley EA
Am J Physiol Heart Circ Physiol; 2018 Aug; 315(2):H348-H356. PubMed ID: 29775410
[TBL] [Abstract][Full Text] [Related]
2. Gαi-biased apelin analog protects against isoproterenol-induced myocardial dysfunction in rats.
Coquerel D; Delile E; Dumont L; Chagnon F; Murza A; Sainsily X; Salvail D; Sarret P; Marsault E; Auger-Messier M; Lesur O
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1646-H1656. PubMed ID: 33635165
[TBL] [Abstract][Full Text] [Related]
3. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
[TBL] [Abstract][Full Text] [Related]
4. APJ acts as a dual receptor in cardiac hypertrophy.
Scimia MC; Hurtado C; Ray S; Metzler S; Wei K; Wang J; Woods CE; Purcell NH; Catalucci D; Akasaka T; Bueno OF; Vlasuk GP; Kaliman P; Bodmer R; Smith LH; Ashley E; Mercola M; Brown JH; Ruiz-Lozano P
Nature; 2012 Aug; 488(7411):394-8. PubMed ID: 22810587
[TBL] [Abstract][Full Text] [Related]
5. Apelin/APJ system: A bifunctional target for cardiac hypertrophy.
Lu L; Wu D; Li L; Chen L
Int J Cardiol; 2017 Mar; 230():164-170. PubMed ID: 27979574
[TBL] [Abstract][Full Text] [Related]
6. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1-Autophagy Pathway Mediated Cardiomyocyte Hypertrophy Induced by Apelin-13.
Wu D; Xie F; Xiao L; Feng F; Huang S; He L; Liu M; Zhou Q; Li L; Chen L
DNA Cell Biol; 2017 Aug; 36(8):611-618. PubMed ID: 28537760
[TBL] [Abstract][Full Text] [Related]
8. Endogenous regulation of cardiovascular function by apelin-APJ.
Charo DN; Ho M; Fajardo G; Kawana M; Kundu RK; Sheikh AY; Finsterbach TP; Leeper NJ; Ernst KV; Chen MM; Ho YD; Chun HJ; Bernstein D; Ashley EA; Quertermous T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1904-13. PubMed ID: 19767528
[TBL] [Abstract][Full Text] [Related]
9. Lactation Is a Risk Factor of Postpartum Heart Failure in Mice with Cardiomyocyte-specific Apelin Receptor (APJ) Overexpression.
Murata K; Ishida J; Ishimaru T; Mizukami H; Hamada J; Saito C; Fukamizu A
J Biol Chem; 2016 May; 291(21):11241-51. PubMed ID: 27033703
[TBL] [Abstract][Full Text] [Related]
10. [Sacubitril/valsartan attenuates left ventricular remodeling and improve cardiac function by upregulating apelin/APJ pathway in rats with heart failure].
Liu HZ; Gao CY; Yuan F; Xu Y; Tian H; Wang SQ; Zhang PF; Shi YN; Wei JJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):690-697. PubMed ID: 35856226
[No Abstract] [Full Text] [Related]
11. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.
Sheikh AY; Chun HJ; Glassford AJ; Kundu RK; Kutschka I; Ardigo D; Hendry SL; Wagner RA; Chen MM; Ali ZA; Yue P; Huynh DT; Connolly AJ; Pelletier MP; Tsao PS; Robbins RC; Quertermous T
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H88-98. PubMed ID: 17906101
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity.
Hamada J; Baasanjav A; Ono N; Murata K; Kako K; Ishida J; Fukamizu A
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H931-41. PubMed ID: 25681427
[TBL] [Abstract][Full Text] [Related]
13. Disruption of actin dynamics regulated by Rho effector mDia1 attenuates pressure overload-induced cardiac hypertrophic responses and exacerbates dysfunction.
Abe I; Terabayashi T; Hanada K; Kondo H; Teshima Y; Ishii Y; Miyoshi M; Kira S; Saito S; Tsuchimochi H; Shirai M; Yufu K; Arakane M; Daa T; Thumkeo D; Narumiya S; Takahashi N; Ishizaki T
Cardiovasc Res; 2021 Mar; 117(4):1103-1117. PubMed ID: 32647865
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of apelin on cardiomyocyte contractility and electrophysiology.
Farkasfalvi K; Stagg MA; Coppen SR; Siedlecka U; Lee J; Soppa GK; Marczin N; Szokodi I; Yacoub MH; Terracciano CM
Biochem Biophys Res Commun; 2007 Jun; 357(4):889-95. PubMed ID: 17466269
[TBL] [Abstract][Full Text] [Related]
15. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
Chen X; Bai B; Tian Y; Du H; Chen J
J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
[TBL] [Abstract][Full Text] [Related]
16. The microRNA-204-5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction.
Gaddam RR; Kim YR; Jacobs JS; Yoon JY; Li Q; Cai A; Shankaiahgari H; London B; Irani K; Vikram A
Clin Transl Med; 2022 Jan; 12(1):e693. PubMed ID: 35060347
[TBL] [Abstract][Full Text] [Related]
17. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441
[TBL] [Abstract][Full Text] [Related]
18. (3R)‑5,6,7‑trihydroxy‑3‑isopropyl‑3‑methylisochroman‑1‑one attenuates cardiac dysfunction via the apelin/APJ signaling pathway.
Ding M; Guan L; Zhang C; Yang P; Yang H
Mol Med Rep; 2019 Jun; 19(6):5007-5014. PubMed ID: 30942406
[TBL] [Abstract][Full Text] [Related]
19. The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy.
Pang H; Han B; Yu T; Peng Z
PLoS One; 2014; 9(3):e92216. PubMed ID: 24647357
[TBL] [Abstract][Full Text] [Related]
20. Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential.
Pang B; Jiang YR; Xu JY; Shao DX; Hao LY
Eur J Pharmacol; 2023 Jun; 949():175727. PubMed ID: 37062502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
